Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day; the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day; This spontaneous case was reported by a patient and describes the occurrence of RHINORRHOEA (the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day) and COVID-19 (the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day) in an elderly male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7144B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In February 2023, the patient experienced RHINORRHOEA (the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day) and COVID-19 (the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day). At the time of the report, RHINORRHOEA (the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day) and COVID-19 (the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2023, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Reportedly, the patient received his first Moderna COVID-19 vaccine on 15-Jan-2021 with lot number 026L20A. Patient received in his left arm. The patient had no adverse reactions or side effects to 1st dose.  The patient received his second Moderna COVID-19 vaccine on 02-Feb-2021 with lot number 029K20A. Patient received in his left arm. The patient had no adverse reactions or side effects to 2nd dose.  The patient received his first booster dose of Moderna COVID-19 vaccine on 24-Aug-2021 with lot number 002F21A. Patient received in his left arm. The patient had no adverse reactions or side effects to first booster dose.  The patient received his second booster dose of Moderna COVID-19 vaccine on 03-Mar-2022 with lot number 045L21A. Patient received in his left arm. The patient had no adverse reactions or side effects to second booster dose.  The patient received his third booster dose of Moderna COVID-19 vaccine on 07-Sep-2022 with lot number AS7144B. Patient received in his left arm. The patient had no adverse reactions or side effects to third booster dose.  In Feb-2023 the patient had a very mild case of COVID-19, the patient tested positive and had the sniffles for one day.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-744661 (Patient Link).